期刊
CLINICAL BREAST CANCER
卷 10, 期 3, 页码 209-216出版社
CIG MEDIA GROUP, LP
DOI: 10.3816/CBC.2010.n.028
关键词
CA 15-3; CA 27.29; Cytokeratins; Disseminated tumor cells; EpCAM; MUC1
类别
Most deaths from breast cancer are from metastatic disease. Tests that predict an individual's risk of developing metastatic disease could be useful. There is growing evidence that circulating tumor cells (CTC) could help predict recurrence and effectiveness of therapy. However, there are unresolved issues with CTC detection methods and their implementation in the community. The utility of CTC testing in the management of breast cancer is unclear based on current studies. This article reviews the role of CTC testing in the management of early and metastatic breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据